Yaxia Chen (Kai Wang)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Endometrial Cancer

Placebo Controlled

Top Venues

Journal of gynecologic oncology

Clinical & experimental metastasis

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology (2023)
Yaxia Chen, Yaxia Chen
Management and prognostic analysis of patients with gestational trophoblastic neoplasia (GTN) in FIGO stage IV and its special type. Clinical & experimental metastasis 38 (1) (2020)